Showing results (41-50 of 1,044) with videos related to
Sort By:
Pageof 105
Thorax|February 1, 1995
Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humansR I Cargill, B J LipworthEuropean Journal of Clinical Pharmacology|January 1, 1989
Beta-adrenoceptor responses to inhaled salbutamol in normal subjectsB J Lipworth, D G McDevittQJM : Monthly Journal of the Association of Physicians|November 13, 2015
Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?G P Currie, B J LipworthBritish Journal of Clinical Pharmacology|March 1, 1994
Comparative effects of angiotensin II on Doppler parameters of left and right heart systolic and diastolic blood flowB J Lipworth, K D DaggBritish Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionateB J Lipworth, C M JacksonBritish Journal of Clinical Pharmacology|July 1, 1995
The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculatureR I Cargill, B J LipworthThe Journal of Cardiovascular Surgery|July 1, 1988
Surgical treatment of constrictive pericarditis due to practolol. A case reportB J Lipworth, D G OakleyPulmonary Pharmacology & Therapeutics|August 1, 1997
Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devicesB J Lipworth, D J ClarkThe European Respiratory Journal|August 1, 1997
Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber)B J Lipworth, D J ClarkBritish Journal of Clinical Pharmacology|August 5, 1998
Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devicesB J Lipworth, D J ClarkPageof 105